Ogura, A. ., Akiyoshi, T. ., Yamamoto, N. ., Kawachi, H. ., Ishikawa, Y. ., Mori, S. ., … Ueno, M. . (2018). Pattern of programmed cell death-ligand 1 expression and CD8-positive T-cell infiltration before and after chemoradiotherapy in rectal cancer. European Journal of Cancer (Oxford, England : 1990), 91, 11-20. https://doi.org/10.1016/j.ejca.2017.12.005 (Original work published 2018)

Kanauchi, O. ., Andoh, A. ., AbuBakar, S. ., & Yamamoto, N. . (2018). Probiotics and Paraprobiotics in Viral Infection: Clinical Application and Effects on the Innate and Acquired Immune Systems. Current Pharmaceutical Design. https://doi.org/10.2174/1381612824666180116163411 (Original work published 2018)

Wu, Y. ., Yang, J. ., Kim, D. ., Lu, S. ., Zhou, J. ., Seto, T. ., … Goto, K. . (2018). Phase II Study of Crizotinib in East Asian Patients With ROS1-Positive Advanced Non-Small-Cell Lung Cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, 36(14), 1405-1411. https://doi.org/10.1200/JCO.2017.75.5587 (Original work published 2018)

Fujiwara, Y. ., Kenmotsu, H. ., Yamamoto, N. ., Shimizu, T. ., Yonemori, K. ., Ocampo, C. ., … Murakami, H. . (2021). Phase 1 study of telisotuzumab vedotin in Japanese patients with advanced solid tumors. Cancer Medicine, 10(7), 2350-2358. https://doi.org/10.1002/cam4.3815